Trial Profile
Phase III study of Garenoxacin in the treatment of community-acquired pneumonia- A randomized, multi-center, double-blind, double-dummy and comparative study-
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Oct 2018
Price :
$35
*
At a glance
- Drugs Garenoxacin (Primary) ; Levofloxacin
- Indications Community-acquired pneumonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Toyama Chemical
- 04 Jun 2016 New trial record